CYPRUMED
CYPRUMED® is a biopharmaceutical company developing a next generation platform technology for the oral delivery of polypeptides. The patent pending technology is entirely based on GRAS listed compounds and easy to formulate. In vivo studies with various polypeptide drugs in rodents, dogs and none human primates showed oral bioavailability up to 70% (rel. s.c.).
CYPRUMED
Industry:
Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Obsteig, Tirol, Austria
Country:
Austria
Website Url:
http://www.cyprumed.net
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1000 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.cyprumed.net
- Host name: mail.31751-2.whserv.de
- IP address: 89.107.190.180
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "CYPRUMED"
About us | Cyprumed – Changing biodelivery
Cyprumed is led by a team of experts, with long-standing experience and a proven track record in research and development of oral drug delivery systems.Our executive team is supported by an advisory board, comprised of …See details»
CYPRUMED - Crunchbase Company Profile & Funding
Contact Email [email protected] CYPRUMED® is a biopharmaceutical company developing a next generation platform technology for the oral …See details»
Team | Cyprumed – Changing biodelivery
Martin Werle, co-inventor of the Cyprumed technology, held various leadership and management positions in formulation development, corporate strategy and global R&D at Syngenta AG, …See details»
CYPRUMED - VentureRadar
CYPRUMED is a biopharmaceutical company developing a next generation platform technology for the oral delivery of peptide drugs. CYPRUMED GmbH was established in 2015. A clinical …See details»
Cyprumed - Overview, News & Competitors | ZoomInfo.com
View Cyprumed (www.cyprumed.net) location in Austria , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Cyprumed GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cyprumed GmbH of Obsteig, Tirol. Get the latest business insights from Dun & Bradstreet.See details»
Cyprumed - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cyprumed with its drug pipeline, therapeutic area, technology platform, .See details»
CYPRUMED - Crunchbase
CYPRUMED is a biopharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
CYPRUMED Company Profile - Office Locations, Competitors
CYPRUMED has 1 employees at their 1 location. See insights on CYPRUMED including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Life Sciences Directory: Cyprumed GmbH
CYPRUMED GmbH, is an Austrian drug delivery company developing enabling technologies for the non-invasive delivery of biologics, with a focus on oral peptide delivery. Key activities …See details»
Technology | Cyprumed – Changing biodelivery
Cyprumed has observed that for certain peptides, gastric delivery results in higher bioavailability than that after intestinal delivery. Our proprietary gastric delivery technology platform is based …See details»
Cyprumed | Scientist.com
Cyprumed is a drug delivery company with a patent protected platform technology for the oral and nasal delivery of therapeutic peptides and proteins. Cyprumed offers the development of oral …See details»
Cyprumed GmbH - Obsteig, Austria - bionity.com
Jan 31, 2022 cyprumed.net +43 6607684977. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. Start-up. Cyprumed GmbH. Kreidweg 27 6416 …See details»
CYPRUMED - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 3, 2016: Seed Round - …See details»
Areas of expertise | Cyprumed – Changing biodelivery
Cyprumed has ongoing pharma collaborations in the field of oral PROTAC delivery. We help you to develop a best-in-class tablet formulation for your BCS IV compound. News. Stay informed …See details»
CYPRUMED - Contacts, Employees, Board Members, Advisors
CYPRUMED has 2 current employee profiles, including Chief Operating Officer Martin Werle. CYPRUMED has 2 board members and advisors, including Jürg Meier . ContactsSee details»
Cyprumed Locations - Contract Research Map
Cyprumed offers the development of oral and nasal formulations for novel and generic biologics such as peptides and also larger proteins. The delivery technology is entirely based on GRAS …See details»
News | Cyprumed – Changing biodelivery
Cyprumed is a dedicated drug delivery company based in Innsbruck, Austria. Our main focus is the development of proprietary technology platforms for the oral administration of therapeutic …See details»
Cyprumed Press Release 24.01.2022 Oral Drug Delivery …
Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics Innsbruck, Austria …See details»